| | SLO | ENG | Piškotki in zasebnost

Večja pisava | Manjša pisava

Izpis gradiva Pomoč

Naslov:Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients
Avtorji:ID Fokter Dovnik, Nina (Avtor)
ID Takač, Iztok (Avtor)
Datoteke:.pdf Radiology_and_Oncology_2017_Dovnik,_Takac_Prognostic_significance_of_uPAPAI-1_level,_HER2_status,_and_traditional_histologic_factors_for.pdf (577,15 KB)
MD5: 1140BBE72E4FAF57632838893A39663C
 
URL http://www.degruyter.com/view/j/raon.2017.51.issue-1/raon-2016-0024/raon-2016-0024.xml
 
Jezik:Angleški jezik
Vrsta gradiva:Znanstveno delo
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:MF - Medicinska fakulteta
Opis:Background: The association of HER2 status with urokinase plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1) levels raises the question whether uPA/PAI-1 level carries additional clinically relevant prognostic information independently from HER2 status. The aim of our study was to compare the prognostic value of uPA/PAI-1 level, HER2 status, and traditional prognostic factors for survival in node-negative breast cancer patients. Patients and methods: A retrospective analysis of 858 node-negative breast cancer patients treated in Maribor University Clinical Center, Slovenia, in the years 2000-2009 was performed. Data were obtained from patient medical records. The median follow-up time was 100 months. Univariate and multivariate analyses of disease-free (DFS) and overall survival (OS) were performed using the Cox regression and the Cox proportional hazards model. Results: In univariate analysis, age, tumor size, grade, lymphovascular invasion, HER2 status and UPA/PAI-1 level were associated with DFS, and age, tumor size, grade, and uPA/PAI-1 level were associated with OS. In the multivariate model, the most important determinants of DFS were age, estrogen receptor status and uPA/PAI-1 level, and the most important factors for OS were patient age and tumor grade. The HR for death from any cause in the multivariate model was 1.98 (95% CI 0.83-4.76) for patients with high uPA and/or PAI-1 compared to patients with both values low. Conclusions: uPA/PAI-1 level clearly carries an independent prognostic value regardless of HER2 status in node-negative breast cancer and could be used in addition to HER2 and other markers to guide clinical decisions in this setting.
Ključne besede:node-negative breast cancer, adjuvant systemic treatment, survival, uPA/PAI-1, HER2 status
Status publikacije:Objavljeno
Verzija publikacije:Objavljena publikacija
Leto izida:2017
Št. strani:str. 65-73
Številčenje:Letn. 51, št. 1
PID:20.500.12556/DKUM-65612 Novo okno
ISSN:1581-3207
UDK:618.19-006
COBISS.SI-ID:5717567 Novo okno
DOI:10.1515/raon-2016-0024 Novo okno
ISSN pri članku:1581-3207
NUK URN:URN:SI:UM:DK:3AHMOAMK
Datum objave v DKUM:10.05.2017
Število ogledov:1357
Število prenosov:395
Metapodatki:XML DC-XML DC-RDF
Področja:Ostalo
:
Kopiraj citat
  
Skupna ocena:(0 glasov)
Vaša ocena:Ocenjevanje je dovoljeno samo prijavljenim uporabnikom.
Objavi na:Bookmark and Share


Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.

Gradivo je del revije

Naslov:Radiology and oncology
Založnik:Association of Radiology and Oncology
ISSN:1581-3207
COBISS.SI-ID:784507 Novo okno

Licence

Licenca:CC BY-NC-ND 4.0, Creative Commons Priznanje avtorstva-Nekomercialno-Brez predelav 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by-nc-nd/4.0/deed.sl
Opis:Najbolj omejujoča licenca Creative Commons. Uporabniki lahko prenesejo in delijo delo v nekomercialne namene in ga ne smejo uporabiti za nobene druge namene.
Začetek licenciranja:10.05.2017

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:dojka, rak (medicina), adjuvantno sistemsko zdravljenje, urokinazni aktivator plazminogena, plazminogen aktivator, inhibitor 1, HER2 status, prognoza


Komentarji

Dodaj komentar

Za komentiranje se morate prijaviti.

Komentarji (0)
0 - 0 / 0
 
Ni komentarjev!

Nazaj
Logotipi partnerjev Univerza v Mariboru Univerza v Ljubljani Univerza na Primorskem Univerza v Novi Gorici